CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 62 filers reported holding CARDIFF ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 19.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,434 | -5.4% | 18,298 | 0.0% | 0.01% | -40.0% |
Q2 2023 | $26,898 | -10.9% | 18,298 | 0.0% | 0.01% | -37.5% |
Q1 2023 | $30,192 | +17.9% | 18,298 | 0.0% | 0.02% | +23.1% |
Q4 2022 | $25,617 | -8.5% | 18,298 | 0.0% | 0.01% | +30.0% |
Q3 2022 | $28,000 | -62.2% | 18,298 | -45.9% | 0.01% | -68.8% |
Q2 2022 | $74,000 | -11.9% | 33,798 | 0.0% | 0.03% | -17.9% |
Q1 2022 | $84,000 | – | 33,798 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |